Chinese Drug Regulator Accepts Haisco Pharma's Application for Pulmonary Disease Drug
Chinese Drug Regulator Accepts Haisco Pharma's Application for Pulmonary Disease Drug
中国药品监管机构接受海思科制药的肺病药物申请
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册